Nuclear localization signal domain of HDAC3 is necessary and sufficient for the expression regulation of MDR1 |
Park, Hyunmi
(Department of Biochemistry, College of Natural Sciences, Kangwon National University)
Kim, Youngmi (Department of Biochemistry, College of Natural Sciences, Kangwon National University) Park, Deokbum (Department of Biochemistry, College of Natural Sciences, Kangwon National University) Jeoung, Dooil (Department of Biochemistry, College of Natural Sciences, Kangwon National University) |
1 | Ott, P. A., Chang, J., Madden, K., Kannan, R., Muren, C., Escano, C., Cheng, X., Shao, Y., Mendoza, S., Gandhi, A., Liebes, L. and Pavlick, A. C. (2013) Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial. Cancer Chemother. Pharmacol. 71, 183-191. DOI ScienceOn |
2 | Chae, S., Kim, Y. B., Lee, J. S. and Cho, H. (2012) Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis. Am. J. Physiol. Gastrointest. Liver Physiol. 302, 1016-1024. DOI ScienceOn |
3 | Mechetner, E., Kyshtoobayeva, A., Zonis, S., Kim, H., Stroup, R., Garcia, R., Parker, R. J. and Fruehauf, J. P. (1998) Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin. Cancer Res. 4, 389-398. |
4 | Yatouji, S., El-Khoury, V., Trentesaux, C., Trussardi-Regnier, A., Benabid, R., Bontems, F. and Dufer, J. (2007) Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines. Int. J. Oncol. 30, 1003-1009. |
5 | Kim, Y. K., Kim, N. H., Hwang, J. W., Song, Y. J., Park, Y. S., Seo, D. W., Lee, H. Y., Choi, W. S., Han, J. W. and Kim, S. N. (2008) Histone deacetylase inhibitor apicidin-mediated drug resistance: involvement of P-glycoprotein. Biochem. Biophys. Res. Commun. 368, 959-964. DOI ScienceOn |
6 | To, K. K., Polgar, O., Huff, L. M., Morisaki, K. and Bates, S. E. (2008) Histone modifications at the ABCG2 promoter following treatment with histone deacetylase inhibitor mirror those in multidrug-resistant cells. Mol. Cancer Res. 6, 151-164. DOI ScienceOn |
7 | Zhang, X., Ozawa, Y., Lee, H., Wen, Y. D., Tan, T. H., Wadzinski, B. E. and Seto, E. (2005) Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 19, 827-839. DOI ScienceOn |
8 | Yang, W. M., Tsai, S. C., Wen, Y. D., Fejer, G. and Seto, E. (2002) Functional domains of histone deacetylase-3. J. Biol. Chem. 277, 9447-9454. DOI ScienceOn |
9 | Takami, Y. and Nakayama, T. (2000) N-terminal region, C-terminal region, nuclear export signal, and deacetylation activity of histone deacetylase-3 are essential for the viability of the DT40 chicken B cell line. J. Biol. Chem. 275, 16191-16201. DOI ScienceOn |
10 | Zhou, C., Shen, Q., Xue, J., Ji, C. and Chen, J. (2013) Overexpression of TTRAP inhibits cell growth and induces apoptosis in osteosarcoma cells. BMB Rep. 46, 113-118 과학기술학회마을 DOI ScienceOn |
11 | Back, S. S., Kim, J., Choi, D., Lee, E. S., Choi, S. Y. and Han, K. (2013) Cooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor. BMB Rep. 46, 322-327 과학기술학회마을 DOI ScienceOn |
12 | Zhang, J., Kalkum, M., Chait, B. T. and Roeder, R. G. (2002) The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9, 611-623. DOI ScienceOn |
13 | Toth, M., Boros, L. M. and Balint, M. (2012) Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multi-drug resistant cells. Cancer Science 103, 659-669. DOI ScienceOn |
14 | Mahlknecht, U., Emiliani, S., Najfeld, V., Young, S. and E. Verdin, E. (1999) Genomic organization and chromosomal localization of the human histone deacetylase 3 gene. Genomics 56, 197-202. DOI ScienceOn |
15 | Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J. M., Qin, J. and Wong, J. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342-4350. DOI ScienceOn |
16 | Mahlknecht, U., Will, J., Varin, A., Hoelzer, D. and Herbein, G. (2004) Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression. J. Immunol. 173, 3979-3990. DOI |
17 | Bardai, F. H. and D'Mello, S. R. (2011) Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta. J. Neurosci. 31, 1746-1751. DOI ScienceOn |
18 | Kim, H. C., Choi, K. C., Choi, H. K., Kang, H. B., Kim, M. J., Lee, Y. H., Lee, O. H., Lee, J., Kim, Y. J., Jun, W., Jeong, J. W. and Yoon, H. G. (2010) HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells. Cell. Mol. Life Sci. 67, 3499-3510. DOI |
19 | Xu, R., Sato, N., Yanai, K., Akiyoshi, T., Nagai, S., Wada, J., Koga, K., Mibu, R., Nakamura, M., and Katano, M. (2009) Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells. Anticancer Res. 29, 261-270. |
20 | Kim, Y., Park, H., Park, D., Lee, Y. S., Choe, J., Hahn, J. H., Lee, H., Kim, Y. M. and Jeoung, D. (2010) Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. J. Biol. Chem. 285, 25957-25968. DOI ScienceOn |
21 | Bhaskara, S., Knutson, S. K., Jiang, G., Chandrasekharan, M. B., Wilson, A. J., Zheng, S., Yenamandra, A., Locke, K., Yuan, J. L., Bonine-Summers, A. R., Wells, C. E., Kaiser, J. F., Washington, M. K., Zhao, Z., Wagner, F. F., Sun, Z. W., Xia, F., Holson, E. B., Khabele, D. and Hiebert, S. W. (2010) Hdac3 is essential for the maintenance of chromatin structure and genome stability. Cancer Cell. 18, 436-447. DOI ScienceOn |